LD 423 | 58336-37-1

Product Introduction

LD 423 is an outstanding and meticulously designed compound that exerts its remarkable therapeutic effects by displaying potent and selective inhibitory properties towards the prominent enzymatic presence of dipeptidyl peptidase-4 (DPP-4). This compound occupies a preeminent position in the domain of Type 2 diabetes management owing to its exceptional faculty to effectively modulate the critical aspect of blood glucose levels. A phenomenon worthy of note is LD 423's intrinsic competence to bolster the secretion of insulin while simultaneously impeding the release of glucagon, thus substantiating its profound efficacy in ameliorating this intricate disease state and ultimately elevating the overall prognosis of the afflicted patients.

Chemical Information
Synonyms	1,2,3,8-tetrahydro-1,2,3,3,5-pentamethyl-7H-pyrrolo[3,2-g]quinolin-7-one
Canonical SMILES	CC1C(C2=C(N1C)C=C3C(=C2)C(=CC(=O)N3)C)(C)C
InChI	InChI=1S/C16H20N2O/c1-9-6-15(19)17-13-8-14-12(7-11(9)13)16(3,4)10(2)18(14)5/h6-8,10H,1-5H3,(H,17,19)
InChI Key	CMSOFVRQNSYALT-UHFFFAOYSA-N
Appearance	Pale White Crystals